Learn More
Medchemexpress LLC PXS-5505 anhydrous (LOX-IN-3 dihydrochloride) | 2409964-23-2 | 99.9% | 353.24 | 50 MG

Supplier: Medchemexpress LLC HY138625A50MG
PXS-5505 anhydrous, also known as LOX-IN-3 dihydrochloride, is an orally active inhibitor of lysyl oxidase (LOX). This compound has potential applications in research related to fibrosis, cancer, and angiogenesis.
- Orally active lysyl oxidase inhibitor.
- Can be used for fibrosis research.
- Can be used for cancer research.
- Can be used for angiogenesis research.
- Inhibits human LOXL2 activity with an IC50 value of <1 μM.
- Inhibits bovine LOX activity with an IC50 value of <10 μM.
- Exhibits sustained inhibition of LOXL1 and LOXL2.
- Less active against SSAO/VAP-1 and MAO-B activities.
- Completely abolished lysyl oxidase activity in rats at 30 mg/kg orally.
- Reduces kidney fibrosis in unilateral ureteric obstruction (UUO) mice model at 10 mg/kg orally.
- Reduces lung fibrosis in mice at 15 mg/kg orally in a bleomycin-induced model.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.